Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy.
Saved in:
| Title: | Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy. |
|---|---|
| Authors: | Munawar U; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Thurner J; School of Life Sciences, Technical University of Munich, Freising, Germany., Nerreter S; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Nerreter T; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Leipold AM; Helmholtz Institute for RNA-based Infection Research, Helmholtz Centre for Infection Research, Wuerzburg, Germany.; Institute of Molecular Infection Biology, University of Wuerzburg, Wuerzburg, Germany., Han S; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Verbruggen C; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Gerhard-Hartmann E; Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany., Vogt C; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Grams B; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Kurian S; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Besant E; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Roth S; Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany., Weingart J; Department of Biotechnology and Biophysics, University of Wuerzburg, Wuerzburg, Germany., Eiring P; Department of Biotechnology and Biophysics, University of Wuerzburg, Wuerzburg, Germany., Truger M; MLL Munich Leukemia Laboratory, Munich, Germany., Afrin N; Mildred Scheel Early Career Center (MSNZ), University Hospital Wuerzburg, Wuerzburg, Germany., Steinbrunn T; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Tamamushi Y; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Zhou X; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Rein N; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Lehmann J; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Köppel M; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Rosenwald A; Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Hudecek M; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Saliba AE; Helmholtz Institute for RNA-based Infection Research, Helmholtz Centre for Infection Research, Wuerzburg, Germany.; Institute of Molecular Infection Biology, University of Wuerzburg, Wuerzburg, Germany., Rasche L; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.; Mildred Scheel Early Career Center (MSNZ), University Hospital Wuerzburg, Wuerzburg, Germany., Sauer M; Department of Biotechnology and Biophysics, University of Wuerzburg, Wuerzburg, Germany., Einsele H; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Kuster B; School of Life Sciences, Technical University of Munich, Freising, Germany., Waldschmidt J; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.; INTERACT Advanced Clinician Scientist-Program, University of Wuerzburg, Wuerzburg, Germany., Kortüm KM; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany. kortuem_m@ukw.de. |
| Source: | Leukemia [Leukemia] 2026 Jun; Vol. 40 (6), pp. 1227-1239. Date of Electronic Publication: 2026 Mar 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41917280 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Munawar+U%22">Munawar U</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Thurner+J%22">Thurner J</searchLink>; School of Life Sciences, Technical University of Munich, Freising, Germany.<br /><searchLink fieldCode="AU" term="%22Nerreter+S%22">Nerreter S</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Nerreter+T%22">Nerreter T</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Leipold+AM%22">Leipold AM</searchLink>; Helmholtz Institute for RNA-based Infection Research, Helmholtz Centre for Infection Research, Wuerzburg, Germany.; Institute of Molecular Infection Biology, University of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Han+S%22">Han S</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Verbruggen+C%22">Verbruggen C</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Gerhard-Hartmann+E%22">Gerhard-Hartmann E</searchLink>; Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Vogt+C%22">Vogt C</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Grams+B%22">Grams B</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kurian+S%22">Kurian S</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Besant+E%22">Besant E</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Roth+S%22">Roth S</searchLink>; Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Weingart+J%22">Weingart J</searchLink>; Department of Biotechnology and Biophysics, University of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Eiring+P%22">Eiring P</searchLink>; Department of Biotechnology and Biophysics, University of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Truger+M%22">Truger M</searchLink>; MLL Munich Leukemia Laboratory, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Afrin+N%22">Afrin N</searchLink>; Mildred Scheel Early Career Center (MSNZ), University Hospital Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Steinbrunn+T%22">Steinbrunn T</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Tamamushi+Y%22">Tamamushi Y</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Zhou+X%22">Zhou X</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Rein+N%22">Rein N</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Lehmann+J%22">Lehmann J</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Köppel+M%22">Köppel M</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Rosenwald+A%22">Rosenwald A</searchLink>; Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Haferlach+C%22">Haferlach C</searchLink>; MLL Munich Leukemia Laboratory, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Hudecek+M%22">Hudecek M</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Saliba+AE%22">Saliba AE</searchLink>; Helmholtz Institute for RNA-based Infection Research, Helmholtz Centre for Infection Research, Wuerzburg, Germany.; Institute of Molecular Infection Biology, University of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Rasche+L%22">Rasche L</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.; Mildred Scheel Early Career Center (MSNZ), University Hospital Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Sauer+M%22">Sauer M</searchLink>; Department of Biotechnology and Biophysics, University of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Einsele+H%22">Einsele H</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kuster+B%22">Kuster B</searchLink>; School of Life Sciences, Technical University of Munich, Freising, Germany.<br /><searchLink fieldCode="AU" term="%22Waldschmidt+J%22">Waldschmidt J</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.; INTERACT Advanced Clinician Scientist-Program, University of Wuerzburg, Wuerzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kortüm+KM%22">Kortüm KM</searchLink>; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany. kortuem&#95;m@ukw.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2026 Jun; Vol. 40 (6), pp. 1227-1239. <i>Date of Electronic Publication: </i>2026 Mar 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41917280 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-026-02920-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1227 Titles: – TitleFull: Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Munawar U – PersonEntity: Name: NameFull: Thurner J – PersonEntity: Name: NameFull: Nerreter S – PersonEntity: Name: NameFull: Nerreter T – PersonEntity: Name: NameFull: Leipold AM – PersonEntity: Name: NameFull: Han S – PersonEntity: Name: NameFull: Verbruggen C – PersonEntity: Name: NameFull: Gerhard-Hartmann E – PersonEntity: Name: NameFull: Vogt C – PersonEntity: Name: NameFull: Grams B – PersonEntity: Name: NameFull: Kurian S – PersonEntity: Name: NameFull: Besant E – PersonEntity: Name: NameFull: Roth S – PersonEntity: Name: NameFull: Weingart J – PersonEntity: Name: NameFull: Eiring P – PersonEntity: Name: NameFull: Truger M – PersonEntity: Name: NameFull: Afrin N – PersonEntity: Name: NameFull: Steinbrunn T – PersonEntity: Name: NameFull: Tamamushi Y – PersonEntity: Name: NameFull: Zhou X – PersonEntity: Name: NameFull: Rein N – PersonEntity: Name: NameFull: Lehmann J – PersonEntity: Name: NameFull: Köppel M – PersonEntity: Name: NameFull: Rosenwald A – PersonEntity: Name: NameFull: Haferlach C – PersonEntity: Name: NameFull: Hudecek M – PersonEntity: Name: NameFull: Saliba AE – PersonEntity: Name: NameFull: Rasche L – PersonEntity: Name: NameFull: Sauer M – PersonEntity: Name: NameFull: Einsele H – PersonEntity: Name: NameFull: Kuster B – PersonEntity: Name: NameFull: Waldschmidt J – PersonEntity: Name: NameFull: Kortüm KM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 40 – Type: issue Value: 6 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |